Display   Show 
All: 1 
Review: 0 

1: Brain Res Bull. 2007 Jun 15;73(1-3):81-5. Epub 2007 Mar 2.

Mismatch negativity analysis in drug-resistant epileptic patients implanted with vagus nerve stimulator.

Department of Neuroscience, Clinical Neurology, Pisa University School of Medicine, Via Roma, 67, 56126 Pisa, Italy; Department of Developmental Neuroscience, Stella Maris Scientific Institute, Pisa, Italy.

It is well known that some epileptic patients does not respond to conventional treatments, despite multiple combination of antiepileptic drugs, and they are therefore considered drug-resistant. For these patients, vagal nerve stimulation (VNS) represents a successful alternative to traditional therapy, and it is generally well tolerated; beside benefits on seizure frequency, VNS showed positive effects on cognition and mood. Aim of this study was to investigate short-term memory changes in a group of 12 patients implanted with VNS, through Mismatch Negativity wave (MMN). After 1 year of follow-up, MMN latencies and amplitudes did not show significant changes following VNS implantation, independently on current intensity, as compared with pre-implantation values. In two patients, MMN values, which were abnormal before VNS implantation, showed a major reduction in latency and an increase in amplitude after implantation, suggesting a likely positive effect of VNS on pre-attentive processes investigated by MMN.

PMID: 17499640 [PubMed - in process]

 Display   Show 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17499640&itool=pubmed_DocSum

RETURN TO ARTICLES